NCT03292042

Brief Summary

The aim of this study is to evaluate the effectiveness of a lifestyle intervention, to reduce the risk of metabolic syndrome in patients with serious mental illness who receive treatment with antipsychotic medications. The hypothesis of the study is that: the application of a physical health promotion program in people with serious mental illness, who receive treatment with antipsychotic medications, carried out by a mental health nurse, will decrease the presence of metabolic syndrome and contribute to improve their quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2017

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

September 20, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 25, 2017

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2018

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 2, 2019

Completed
Last Updated

February 28, 2019

Status Verified

September 1, 2017

Enrollment Period

12 months

First QC Date

September 20, 2017

Last Update Submit

February 27, 2019

Conditions

Keywords

metabolic syndromelifestyle interventionhealth promotionmental health nurseserious mental illness

Outcome Measures

Primary Outcomes (1)

  • Decrease of at least 3 of the 5 criteria of metabolic syndrome

    Fasting glucose ≥110 mg/dL (or receiving drug therapy for hyperglycemia) Blood pressure ≥130/85 mm Hg (or receiving drug therapy for hypertension) Triglycerides ≥150 mg/dL (or receiving drug therapy for hypertriglyceridemia) HDL-C \<40 mg/dL in men or \<50 mg/dL in women (or receiving drug therapy for reduced HDL-C) Waist circumference ≥102 cm in men or ≥88 cm in women

    6 months

Secondary Outcomes (4)

  • Metabolic syndrome prevalence

    6 months

  • use of antipsychotic

    6 months

  • Toxic habits

    6 months

  • Quality of life improvement

    6 months

Study Arms (2)

Experimental Group

EXPERIMENTAL

This group will carry out the lifestyle intervention (Physical health promotion program) during 6 months. The group will attend a session per week.

Behavioral: Physical health promotion program

Control group

NO INTERVENTION

usual care

Interventions

The program has 24 sessions. Each session has two parts: * first part: half an hour of theoretical content, about the Metabolic syndrome, the effect of unhealthy lifestyle, toxic habits such as smoking or drinking alcohol, dietary habits or physical activity. * Second part: 1 hour of physical activity (walk)

Experimental Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnostic of serious mental illness.
  • Treatment with antipsychotics.
  • Met at least 3 of the 5 criteria of metabolic syndrome According to the NCEP ATP III definition.

You may not qualify if:

  • Medical contraindications to exercise
  • Admitted to hospital.
  • intellectual disability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

university hospital Ramón y Cajal

Madrid, 28034, Spain

Location

MeSH Terms

Conditions

Metabolic Syndrome

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 20, 2017

First Posted

September 25, 2017

Study Start

September 1, 2017

Primary Completion

August 31, 2018

Study Completion

February 2, 2019

Last Updated

February 28, 2019

Record last verified: 2017-09

Locations